Rituximab

Rituximab Reactions 1704, p333 - 2 Jun 2018 Infusion reaction: case report In a retrospective data collection study, one patient [age and sex not stated] was described, who developed infusion reaction during treatment with rituximab for chronic immune thrombocytopenia (cITP). The patient was administered rituximab 375 mg/m weekly for 4 weeks. The patient developed grade 2 infusion reaction; however, the treatment was not discontinued [time to reaction onset and outcome not stated]. Author comment: "[One] patient had a Grade 2 infusion reaction according to NCI-CTC criteria but did not require discontinuation". Kundu S, et al. Single hospital retrospective review of the use of monoclonal antibody and its biosimilar truxima in chronic immune thrombocytopenia. British Journal of Haematology 181 (Suppl. 1): 163 abstr. BSH18-EP-010, Apr 2018. Available from: URL: http://doi.org/10.1111/bjh.15226 [abstract] - United Kingdom 803323279 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Rituximab

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/rituximab-HnUt01mni4
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46976-z
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p333 - 2 Jun 2018 Infusion reaction: case report In a retrospective data collection study, one patient [age and sex not stated] was described, who developed infusion reaction during treatment with rituximab for chronic immune thrombocytopenia (cITP). The patient was administered rituximab 375 mg/m weekly for 4 weeks. The patient developed grade 2 infusion reaction; however, the treatment was not discontinued [time to reaction onset and outcome not stated]. Author comment: "[One] patient had a Grade 2 infusion reaction according to NCI-CTC criteria but did not require discontinuation". Kundu S, et al. Single hospital retrospective review of the use of monoclonal antibody and its biosimilar truxima in chronic immune thrombocytopenia. British Journal of Haematology 181 (Suppl. 1): 163 abstr. BSH18-EP-010, Apr 2018. Available from: URL: http://doi.org/10.1111/bjh.15226 [abstract] - United Kingdom 803323279 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off